Author

A. Chalumeau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. Miccio· 1 shared B. MLAYAH· 1 shared G. Frati· 1 shared G. Hardouin· 1 shared G. Sartre· 1 shared G. Turchiano· 1 shared J.-P. Concordet· 1 shared M. Brusson· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Miccio

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Safety and efficacy study of CRISPR/Cas9 treatment of sickle cell disease in clinically relevant conditions highlights disease-specific response

G. Frati, M. Brusson, G. Sartre, B. MLAYAH, T. FELIX, A. Chalumeau, P. Antoniou, G. Hardouin, J.-P. Concordet, O. Romano, G. Turchiano, A. Miccio

This study evaluates the safety and efficacy of CRISPR/Cas9-mediated HbF reactivation in sickle cell disease by testing it in patient-derived HSPCs and shows it is effective but has off-target effects.

bioRxiv · Jan 14, 2024Bioengineering